Dariusz Boroń

Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women

BackgroundRecognition of different genetic variants underlying osteoporosis would make it possible to introduce individual, symptomatic treatment as well as early prophylaxis of osteoporosis.The aim of the study was to evaluate the frequency of the rs2275913 (−197G > A) polymorphism of the IL-17 gene and assess the relation of this polymorphism with the clinical parameters of the osseous turnover and degree of the postmenopausal osteoporosis.MethodsThe study included 800 women of postmenopausal (505) and reproductive (295) ages throughout the Wielkopolska region in Poland. The postmenopausal group included women with osteoporosis and osteopenia, and those who were healthy. Women at reproductive age were healthy. The frequency of the tested gene polymorphism was evaluated in the group where bone mineral density (BMD) was marked and in the control group.ResultsThe results obtained showed that the T-score in the female population with osteopenia was remarkably lower in women showing the GG genotype of -197G > A polymorphism of IL-17 gene compared to patients with heterozygous GA genotype. It has been shown that the BMD value for L2–L4 YA in the evaluated female population with osteoporosis is significantly higher in women with the GA genotype of -197G > A polymorphism of IL-17 gene compared to women with the GG genotype (76.32% versus 59.93%, P <0.05). It has also been noted that the BMD value for L2 to L4 AM in patients with the GG genotype was lower than in women with the AA genotype (69.73% versus 80.88%, P <0.05).ConclusionsIt is suggested that the -197G > A polymorphism of the IL-17 gene may be considered as a genetic factor of postmenopausal osteoporosis. This polymorphism can influence the bone mineral density and T-score value in young women and postmenopausal women.

Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women

SummaryPostmenopausal osteoporosis is the most common metabolic bone disease with important genetic factors. We evaluated the frequency of polymorphism 283G/A of the vitamin D3VDR gene receptor. The study included 800 women at the postmenopausal (505) and reproductive (295) age. Statistically significant changes, depending on the genotype, were shown.IntroductionPostmenopausal osteoporosis is the most common metabolic bone disease of strong genetic origin with population variability determined by the interaction of genetic and environmental factors. Recognition of different genetic variants underlying development of osteoporosis would make it possible to administer individual symptomatic treatment as well as early prophylactics of osteoporosis.MethodsThe aim of the study was to evaluate the frequency of polymorphism 283G/A of the vitamin D3VDR gene receptor and assessment of its relations with the clinical parameters of osseous turnover and degree of postmenopausal osteoporosis.The study included 800 women at the postmenopausal (505) and reproductive (295) age throughout the Wielkopolska region in Poland. The postmenopausal group included women with osteoporosis and osteopenia and the healthy ones. Women at the reproductive age were healthy. Frequency of the tested gene polymorphism was evaluated in the group where bone mineral density (BMD) was marked and in the control group.ResultsThe obtained test results pointed to correlation of polymorphism VDR 283G/A with the BMD scores for the lumbar vertebrae in women with osteopenia and osteoporosis, therefore the ones at risk of fractures. Vitamin D receptor (VDR) polymorphism correlated with reduced BMD values.ConclusionsPolymorphism 283G/A of the vitamin D3 receptor gene has been proved to be the genetic factor of postmenopausal osteoporosis. The polymorphism mentioned above has been proved to be a factor of mineral bone density changes of women.

Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women.

OBJECTIVES The aim of the study was to evaluate the frequency of gene polymorphisms OPG -163A/G, -950T/C and 1181G/C, assessing their relations with the clinical parameters of osseous turnover and the degree of postmenopausal osteoporosis. STUDY DESIGN The study included 800 women of postmenopausal (505) and reproductive (295) age from Poland. The postmenopausal group included women with osteoporosis and osteopenia, as well as healthy individuals. All the women of reproductive age were healthy. The frequency of the tested gene polymorphisms was evaluated within the group where BMD (bone mineral density) was marked and also in the control group. MAIN OUTCOME MEASURES The frequencies of the polymorphisms of OPG genotypes in the women were characteristic of the population. RESULTS OPG -950T/C polymorphism has been associated with body weight and birth weight. OPG 1181G/C and OPG -163A/G polymorphisms have been associated not only with body weight and birth weight, but also with reduced bone density and an increased risk of postmenopausal osteoporosis. CONCLUSIONS Evaluation of the polymorphism -950T/C of the OPG gene showed that the CC genotype may appear as an increased risk factor for the faster loss of bone mass and the onset of osteoporosis in Polish postmenopausal women. This polymorphism may be a genetic marker that is responsible for the development of osteoporosis. The homozygous genotypes of polymorphisms 1181G/C and -163A/G of the OPG gene may play a role in increased risks of osteoporosis and may be linked to the birth weights of women.

Omentin Polymorphism and its Relations to Bone Mineral Density in Women.

BACKGROUND AND AIMS Recognition of different genetic variants underlying development of osteoporosis would make it possible to administer individual symptomatic treatment as well as early prophylactics of osteoporosis. The aim of the study was to evaluate frequency of polymorphism 326A/T of gene ITLN-1 and assessment of its relations with the clinical parameters of osseous turnover and degree of postmenopausal osteoporosis. METHODS The study included 800 women at the postmenopausal (505) and reproductive (295) age throughout Wielkopolska region in Poland. The postmenopausal group included women with osteoporosis and osteopenia and the healthy ones. Women at the reproductive age were healthy. Frequency of the tested gene polymorphism was evaluated in the group where BMD was marked and in the control group. RESULTS The analysis of the polymorphism A326T of gene ITLN-1 showed that in healthy postmenopausal female with genotype AA birth weight, BMD L2-L4 YA (%) and BMD L2-L4 AM (%) were significantly higher (BMD-bone mineral density; L2-L4-- lumbar vertebrae no 2, 4; YA--peak adult bone mass; AM--age-matched bone mass). In women with osteopenia BMD L2-L4 YA (%) and BMD L2-L4 AM (%) were significantly higher in women with genotype AA, but BMD L2-L4 was significantly higher in women with genotype TT. In women with osteoporosis with genotype AA T-score was significantly higher, but BMD L2-L4 and BMD L2-L4 YA (%) were significantly lower in this group. BMD L2-L4 AM (%) was significantly higher in women with AA genotype. CONCLUSION In women with osteoporosis and osteopenia homozygous AA genotype may predispose to lower BMD in the lumbar spine.

Determination of chlorogenic and gallic acids by UPLC-MS/MS

Summary The aim of our study were qualitative and quantitative analyses of two polyphenolic acids: chlorogenic and gallic acids. These compounds were determined in two species of Rhodiola: R. kirilowii and R. rosea. After collecting plants, aqueous and hydroalcoholic extracts were prepared. In order to identify analysed polyphenolic compounds ultra performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS, Waters) was used. Gallic acid is commonly found in the roots of these plants. Aqueous extract in both species is a rich source of gallic acid. The UPLC-MS/MS studies allow to use this analytical method for determination of polyphenolic acids accordance with the requirements of ICH. Chromatographic method developed by our team is more precise then previously published. Streszczenie W Instytucie Włókien Naturalnych i Roślin Zielarskich podjęto badania mające na celu opracowanie metody detekcji kwasu chlorogenowego oraz galusowego za pomocą ultrasprawnej chromatografii cieczowej sprzężonej z tandemowym spektrometrem mas (UPLCMS/ MS, Waters). Badaniom poddano dwa gatunki różnica: Rhodiola kirilowii oraz R. rosea. Rośliny zostały wyhodowane w uprawie gruntowej w Instytucie. Przeprowadzona walidacja metody pozwoliła na jej wykorzystanie w ocenie zawartości kwasu chlorogenowego oraz galusowego w badanych roślinach, ponieważ zawartość analizowanych związków zależna jest zarówno od gatunku jak i warunków uprawy.

Incorporation of [3H]uridine and [3H]glycine in the brain of rats prenatally exposure to cadmium

Numerous studies have demonstrated that exposure of mammalians, including humans to inorganic cadmium, result in a cascade of toxic effects. The developing mammalian brain is particularly more sensitive to cadmium then the adult brain, being affected both morphologically and neurochemically. Uridine is a precursor of RNA, and the intensity of its incorporation in tissue represents the rate of RNA and protein synthesis. Glicine is an important aminoacid, an element of many proteins and enzymes in mammalian organism. On the first day of pregnancy, Wistar rats were divided into two groups. First, control consumed filtred tap water while other half consumed filtred tap water with 50 ppm cadmium (CdCH3COO2). At eight weeks after birth both groups were injected with [3H]uridine (incorporated to RNA) or [3H]glycine (incorporated to protein) 1 μCi/kg IP. Four hours later rats were sacrificed by decapitation and parts of the brain were excised and examined for radioactivity in liquid scintillation counter. Results were presented as a disintegration per minute (DPM)/100 mg wet tissue weight, which expressed labeled substances incorporation. Prenatal exposure with cadmium significantly decreased [3H]uridine incorporation in all examined parts of the brain (frontal cortex, striatum, thalamus with hypothalamus, pons, hippocampus, cerebellum). Neonatal exposure rats to cadmium decreased incorporation of the [3H]glycine in frontal cortex, thalamus with hypothalamus, pons and cerebellum. From above we concluded and confirmed that prenatal exposure with cadmium exert a toxic effect on RNA and proteins synthesis in the brain of developing rats.